Ocular toxicity of intravitreal trovafloxacin in the pigmented rabbit

Eugene W M Ng, Myung Jin Joo, Kah Guan Au Eong, W. Richard Green, Terrence O'Brien

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Purpose. Trovafloxacin is an expanded spectrum, newer-generation fluoroquinolone antibiotic with improved Gram-positive and anaerobic activity compared with existing quinolones, while maintaining Gram-negative activity comparable to ciprofloxacin. Given its broad spectrum of activity, trovafloxacin may have potential use for treatment of acute bacterial endophthalmitis. This study examined the toxicity of intravitreally administered trovafloxacin in the pigmented rabbit eye. Methods. Doses of trovafloxacin ranging from 12.5 μg to 1000 μg were injected into the mid-vitreous of Dutch Belted rabbit eyes. Clinical examination was performed at 1, 3, and 14 days following injection. Animals were sacrificed and eyes were enucleated 14 days following injection. Light microscopy (LM) and transmission electron microscopy (TEM) studies of the optic nerve head, medullary ray, and inferior retina were performed to determine toxicity. Results. At intravitreal doses of 500 μg and less, no toxicity was observed at the ophthalmoscopic or light microscopic level. By TEM, a dose-dependent increase in injury to retinal pigment epithelium, photoreceptors, and nerve fibers in the optic nerve head and medullary ray was observed from 50 μg to 500 μg. No toxicity was noted at doses of 12.5 μg and 25 μg. At doses of 750 μg and above, edema of the medullary ray was noted on ophthalmoscopy. Swelling of the peripapillary medullary ray and necrosis of the inferior retina were evident on LM. Conclusion. Intravitreal trovafloxacin doses of 50 μg and higher in the pigmented rabbit eye cause retinal and nerve fiber injury. Intravitreal doses 25 μg and lower appear to be safe, with no evidence of ocular toxicity.

Original languageEnglish
Pages (from-to)387-393
Number of pages7
JournalCurrent Eye Research
Volume27
Issue number6
DOIs
StatePublished - Dec 1 2003
Externally publishedYes

Fingerprint

Rabbits
Optic Disk
Transmission Electron Microscopy
Nerve Fibers
Light
Retina
Microscopy
Ophthalmoscopy
Injections
Endophthalmitis
Retinal Pigment Epithelium
Quinolones
Fluoroquinolones
Wounds and Injuries
Ciprofloxacin
Edema
Necrosis
trovafloxacin
Anti-Bacterial Agents
Therapeutics

Keywords

  • Endophthalmitis
  • Intravitreal injection
  • Toxicity
  • Trovafloxacin

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems

Cite this

Ocular toxicity of intravitreal trovafloxacin in the pigmented rabbit. / Ng, Eugene W M; Joo, Myung Jin; Eong, Kah Guan Au; Green, W. Richard; O'Brien, Terrence.

In: Current Eye Research, Vol. 27, No. 6, 01.12.2003, p. 387-393.

Research output: Contribution to journalArticle

Ng, Eugene W M ; Joo, Myung Jin ; Eong, Kah Guan Au ; Green, W. Richard ; O'Brien, Terrence. / Ocular toxicity of intravitreal trovafloxacin in the pigmented rabbit. In: Current Eye Research. 2003 ; Vol. 27, No. 6. pp. 387-393.
@article{02114b1ec1e545c0a1ea8a2faeaa328e,
title = "Ocular toxicity of intravitreal trovafloxacin in the pigmented rabbit",
abstract = "Purpose. Trovafloxacin is an expanded spectrum, newer-generation fluoroquinolone antibiotic with improved Gram-positive and anaerobic activity compared with existing quinolones, while maintaining Gram-negative activity comparable to ciprofloxacin. Given its broad spectrum of activity, trovafloxacin may have potential use for treatment of acute bacterial endophthalmitis. This study examined the toxicity of intravitreally administered trovafloxacin in the pigmented rabbit eye. Methods. Doses of trovafloxacin ranging from 12.5 μg to 1000 μg were injected into the mid-vitreous of Dutch Belted rabbit eyes. Clinical examination was performed at 1, 3, and 14 days following injection. Animals were sacrificed and eyes were enucleated 14 days following injection. Light microscopy (LM) and transmission electron microscopy (TEM) studies of the optic nerve head, medullary ray, and inferior retina were performed to determine toxicity. Results. At intravitreal doses of 500 μg and less, no toxicity was observed at the ophthalmoscopic or light microscopic level. By TEM, a dose-dependent increase in injury to retinal pigment epithelium, photoreceptors, and nerve fibers in the optic nerve head and medullary ray was observed from 50 μg to 500 μg. No toxicity was noted at doses of 12.5 μg and 25 μg. At doses of 750 μg and above, edema of the medullary ray was noted on ophthalmoscopy. Swelling of the peripapillary medullary ray and necrosis of the inferior retina were evident on LM. Conclusion. Intravitreal trovafloxacin doses of 50 μg and higher in the pigmented rabbit eye cause retinal and nerve fiber injury. Intravitreal doses 25 μg and lower appear to be safe, with no evidence of ocular toxicity.",
keywords = "Endophthalmitis, Intravitreal injection, Toxicity, Trovafloxacin",
author = "Ng, {Eugene W M} and Joo, {Myung Jin} and Eong, {Kah Guan Au} and Green, {W. Richard} and Terrence O'Brien",
year = "2003",
month = "12",
day = "1",
doi = "10.1076/ceyr.27.6.387.18192",
language = "English",
volume = "27",
pages = "387--393",
journal = "Current Eye Research",
issn = "0271-3683",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - Ocular toxicity of intravitreal trovafloxacin in the pigmented rabbit

AU - Ng, Eugene W M

AU - Joo, Myung Jin

AU - Eong, Kah Guan Au

AU - Green, W. Richard

AU - O'Brien, Terrence

PY - 2003/12/1

Y1 - 2003/12/1

N2 - Purpose. Trovafloxacin is an expanded spectrum, newer-generation fluoroquinolone antibiotic with improved Gram-positive and anaerobic activity compared with existing quinolones, while maintaining Gram-negative activity comparable to ciprofloxacin. Given its broad spectrum of activity, trovafloxacin may have potential use for treatment of acute bacterial endophthalmitis. This study examined the toxicity of intravitreally administered trovafloxacin in the pigmented rabbit eye. Methods. Doses of trovafloxacin ranging from 12.5 μg to 1000 μg were injected into the mid-vitreous of Dutch Belted rabbit eyes. Clinical examination was performed at 1, 3, and 14 days following injection. Animals were sacrificed and eyes were enucleated 14 days following injection. Light microscopy (LM) and transmission electron microscopy (TEM) studies of the optic nerve head, medullary ray, and inferior retina were performed to determine toxicity. Results. At intravitreal doses of 500 μg and less, no toxicity was observed at the ophthalmoscopic or light microscopic level. By TEM, a dose-dependent increase in injury to retinal pigment epithelium, photoreceptors, and nerve fibers in the optic nerve head and medullary ray was observed from 50 μg to 500 μg. No toxicity was noted at doses of 12.5 μg and 25 μg. At doses of 750 μg and above, edema of the medullary ray was noted on ophthalmoscopy. Swelling of the peripapillary medullary ray and necrosis of the inferior retina were evident on LM. Conclusion. Intravitreal trovafloxacin doses of 50 μg and higher in the pigmented rabbit eye cause retinal and nerve fiber injury. Intravitreal doses 25 μg and lower appear to be safe, with no evidence of ocular toxicity.

AB - Purpose. Trovafloxacin is an expanded spectrum, newer-generation fluoroquinolone antibiotic with improved Gram-positive and anaerobic activity compared with existing quinolones, while maintaining Gram-negative activity comparable to ciprofloxacin. Given its broad spectrum of activity, trovafloxacin may have potential use for treatment of acute bacterial endophthalmitis. This study examined the toxicity of intravitreally administered trovafloxacin in the pigmented rabbit eye. Methods. Doses of trovafloxacin ranging from 12.5 μg to 1000 μg were injected into the mid-vitreous of Dutch Belted rabbit eyes. Clinical examination was performed at 1, 3, and 14 days following injection. Animals were sacrificed and eyes were enucleated 14 days following injection. Light microscopy (LM) and transmission electron microscopy (TEM) studies of the optic nerve head, medullary ray, and inferior retina were performed to determine toxicity. Results. At intravitreal doses of 500 μg and less, no toxicity was observed at the ophthalmoscopic or light microscopic level. By TEM, a dose-dependent increase in injury to retinal pigment epithelium, photoreceptors, and nerve fibers in the optic nerve head and medullary ray was observed from 50 μg to 500 μg. No toxicity was noted at doses of 12.5 μg and 25 μg. At doses of 750 μg and above, edema of the medullary ray was noted on ophthalmoscopy. Swelling of the peripapillary medullary ray and necrosis of the inferior retina were evident on LM. Conclusion. Intravitreal trovafloxacin doses of 50 μg and higher in the pigmented rabbit eye cause retinal and nerve fiber injury. Intravitreal doses 25 μg and lower appear to be safe, with no evidence of ocular toxicity.

KW - Endophthalmitis

KW - Intravitreal injection

KW - Toxicity

KW - Trovafloxacin

UR - http://www.scopus.com/inward/record.url?scp=0347623111&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347623111&partnerID=8YFLogxK

U2 - 10.1076/ceyr.27.6.387.18192

DO - 10.1076/ceyr.27.6.387.18192

M3 - Article

VL - 27

SP - 387

EP - 393

JO - Current Eye Research

JF - Current Eye Research

SN - 0271-3683

IS - 6

ER -